Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1091]
News [2725]
Articles [183]
Editorials [9]
Conferences [110]
elearning [25]

Prostate cancer patients on hormone therapy at increased risk for various heart diseases

Ms Mieke Van Hemelrijck - King's College, London
Prostate cancer patients on hormone therapy at increased risk for various heart diseases ( Ms Mieke Van Hemelrijck - King's College, London )
22 Sep 2009

ECCO 15 - ESMO 34 News 20-21 September, 2009

Prof Gordon McVie - ecancer Managing Editor
ECCO 15 - ESMO 34 News 20-21 September, 2009 ( Prof Gordon McVie - ecancer Managing Editor )
21 Sep 2009

The Oncopolicy Roundtable: ECCO's President and special guests highlight key issues

ECCO 15 - ESMO 34
The Oncopolicy Roundtable: ECCO's President and special guests highlight key issues ( ECCO 15 - ESMO 34 )
22 Jul 2009

ECCO 15 - ESMO 34 Chairs: Why join us in Berlin?

Why attend ECCO 15 - ESMO 34?
ECCO 15 - ESMO 34 Chairs: Why join us in Berlin? ( Why attend ECCO 15 - ESMO 34? )
22 Jul 2009

Targeting death receptors in chemo-resistant cancer cells

Prof Patrick Johnston - Queen's University Belfast, UK
Targeting death receptors in chemo-resistant cancer cells ( Prof Patrick Johnston - Queen's University Belfast, UK )
3 Jul 2009

Zoledronic acid for treament of prostate cancer

Dr. Thomas W. Leonard, Chief Scientific Officer, Merrion Pharmaceuticals
Zoledronic acid for treament of prostate cancer ( Dr. Thomas W. Leonard, Chief Scientific Officer, Merrion Pharmaceuticals )
25 Jun 2009

PSA/Prostate screening

Dr. Otis W. Brawley - Chief Medical Officer, ASCO
PSA/Prostate screening ( Dr. Otis W. Brawley - Chief Medical Officer, ASCO )
25 Jun 2009

AACR 2009: Circulating tumour cells as biomarkers

Dr Howard Scher - Sloan Kettering Memorial Cancer Center
AACR 2009: Circulating tumour cells as biomarkers ( Dr Howard Scher - Sloan Kettering Memorial Cancer Center )
5 Jun 2009

AACR 2009: Common genetic variations and predisposition to cancer

Prof Bruce Ponder - Cancer Research UK, Cambridge Institute
AACR 2009: Common genetic variations and predisposition to cancer ( Prof Bruce Ponder - Cancer Research UK, Cambridge Institute )
14 May 2009

AACR 2009: Anti-angiogenics to tackle brain and prostate tumours

Prof Gabriele Bergers - University of California, San Francisco
AACR 2009: Anti-angiogenics to tackle brain and prostate tumours ( Prof Gabriele Bergers - University of California, San Francisco )
14 May 2009

AACR 2009: 100 years of AACR

Dr Margaret Foti - CEO of the American Association for Cancer Research
AACR 2009: 100 years of AACR ( Dr Margaret Foti - CEO of the American Association for Cancer Research )
14 May 2009

AACR 2009: Chemokine inhibitors to prevent tumour growth

Prof Alberto Mantovani - Professor of General Pathology, University of Milan
AACR 2009: Chemokine inhibitors to prevent tumour growth ( Prof Alberto Mantovani - Professor of General Pathology, University of Milan )
14 May 2009

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation